Repligen Stock Performance
| RGEN Stock | USD 142.12 2.46 1.76% |
The company holds a Beta of 1.56, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Repligen will likely underperform. At this point, Repligen has a negative expected return of -0.046%. Please make sure to check Repligen's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Repligen performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Repligen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Repligen is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (4.41) | Five Day Return (10.66) | Year To Date Return (15.02) | Ten Year Return 563.78 | All Time Return 1.1 K |
1 | Repligen Clears Technical Benchmark, Hitting 80-Plus RS Rating | 11/17/2025 |
2 | Disposition of 2191 shares by James Bylund of Repligen at 151.21 subject to Rule 16b-3 | 11/18/2025 |
3 | Disposition of 2000 shares by Anthony Hunt of Repligen subject to Rule 16b-3 | 12/04/2025 |
4 | Insider Trading | 12/31/2025 |
5 | Repligen Valuation Check As New Board Chair Signals Leadership Continuity | 01/07/2026 |
6 | Acquisition by Douglass Brian Robb of 2143 shares of Repligen at 163.86 subject to Rule 16b-3 | 01/12/2026 |
7 | Why Repligen Shares Are Sliding Today | 01/14/2026 |
8 | Single-Use Bioprocessing Market Projected to Reach US 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica | 01/20/2026 |
9 | UBS Tags Repligen as Bioprocessing Leader for 2026, Cites 20 percent Order Growth and Reshoring Tailwinds | 01/23/2026 |
10 | Mirae Asset Global Investments Co. Ltd. Sells 10,260 Shares of Repligen Corporation RGEN - MarketBeat | 02/03/2026 |
| Begin Period Cash Flow | 751.3 M | |
| Total Cashflows From Investing Activities | -86.4 M |
Repligen Relative Risk vs. Return Landscape
If you would invest 14,566 in Repligen on November 8, 2025 and sell it today you would lose (600.00) from holding Repligen or give up 4.12% of portfolio value over 90 days. Repligen is currently does not generate positive expected returns and assumes 2.215% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than Repligen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Repligen Target Price Odds to finish over Current Price
The tendency of Repligen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 142.12 | 90 days | 142.12 | about 99.0 |
Based on a normal probability distribution, the odds of Repligen to move above the current price in 90 days from now is about 99.0 (This Repligen probability density function shows the probability of Repligen Stock to fall within a particular range of prices over 90 days) .
Repligen Price Density |
| Price |
Predictive Modules for Repligen
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Repligen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Repligen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Repligen Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Repligen is not an exception. The market had few large corrections towards the Repligen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Repligen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Repligen within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | 1.56 | |
σ | Overall volatility | 8.13 | |
Ir | Information ratio | -0.06 |
Repligen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Repligen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Repligen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Repligen generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 634.44 M. Net Loss for the year was (25.51 M) with profit before overhead, payroll, taxes, and interest of 365.19 M. | |
| Repligen has a poor financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Mirae Asset Global Investments Co. Ltd. Sells 10,260 Shares of Repligen Corporation RGEN - MarketBeat |
Repligen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Repligen Stock often depends not only on the future outlook of the current and potential Repligen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Repligen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 55.9 M | |
| Cash And Short Term Investments | 757.4 M |
Repligen Fundamentals Growth
Repligen Stock prices reflect investors' perceptions of the future prospects and financial health of Repligen, and Repligen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Repligen Stock performance.
| Return On Equity | 9.0E-4 | ||||
| Return On Asset | 0.013 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 8.16 B | ||||
| Shares Outstanding | 56.29 M | ||||
| Price To Earning | 154.58 X | ||||
| Price To Book | 3.95 X | ||||
| Price To Sales | 11.11 X | ||||
| Revenue | 634.44 M | ||||
| Gross Profit | 365.19 M | ||||
| EBITDA | 80.26 M | ||||
| Net Income | (25.51 M) | ||||
| Cash And Equivalents | 596.51 M | ||||
| Cash Per Share | 10.75 X | ||||
| Total Debt | 686.25 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 37.01 X | ||||
| Cash Flow From Operations | 175.39 M | ||||
| Earnings Per Share | 0.01 X | ||||
| Market Capitalization | 7.86 B | ||||
| Total Asset | 2.83 B | ||||
| Retained Earnings | 407.35 M | ||||
| Working Capital | 939.25 M | ||||
| Current Asset | 103.25 M | ||||
| Current Liabilities | 18.78 M | ||||
About Repligen Performance
By examining Repligen's fundamental ratios, stakeholders can obtain critical insights into Repligen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Repligen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 130.53 | 133.81 | |
| Return On Tangible Assets | (0.02) | (0.02) | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Repligen performance evaluation
Checking the ongoing alerts about Repligen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Repligen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Repligen generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 634.44 M. Net Loss for the year was (25.51 M) with profit before overhead, payroll, taxes, and interest of 365.19 M. | |
| Repligen has a poor financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Mirae Asset Global Investments Co. Ltd. Sells 10,260 Shares of Repligen Corporation RGEN - MarketBeat |
- Analyzing Repligen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Repligen's stock is overvalued or undervalued compared to its peers.
- Examining Repligen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Repligen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Repligen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Repligen's stock. These opinions can provide insight into Repligen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Life Sciences Tools & Services sector continue expanding? Could Repligen diversify its offerings? Factors like these will boost the valuation of Repligen. Anticipated expansion of Repligen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repligen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.6 | Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.219 | Return On Assets |
Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.